Recurrent Epithelial Cancer of Ovary
2 clinical trials · Condition
◉ Watch Recurrent Epithelial Cancer of Ovary
| Record | Firm | Date |
|---|---|---|
| A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. (NCT05335993) | CanariaBio Inc. | 2022-07-25 |
| Anti-PD-L1 and SAbR for Ovarian Cancer (NCT03312114) | University of Texas Southwestern Medical Center | 2017-11-09 |
Track Recurrent Epithelial Cancer of Ovary automatically
Every clearance here is in the API, with alerts when new ones post.